Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems
Abstract Background Several aerosol production systems have been used for aerosol insulin production. However; since the first studies several new models of jet-nebulizers and ultrasound nebulizers have been introduced in the market.
Gespeichert in:
| Autor*in: |
Zarogoulidis, Paul [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2013 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
9 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides - Nigolian, H. ELSEVIER, 2022, New York, NY [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:458 ; year:2013 ; number:1 ; day:15 ; month:12 ; pages:39-47 ; extent:9 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ijpharm.2013.10.019 |
|---|
| Katalog-ID: |
ELV021961824 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV021961824 | ||
| 003 | DE-627 | ||
| 005 | 20230623162637.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijpharm.2013.10.019 |2 doi | |
| 028 | 5 | 2 | |a GBVA2013012000020.pica |
| 035 | |a (DE-627)ELV021961824 | ||
| 035 | |a (ELSEVIER)S0378-5173(13)00905-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.61 |2 bkl | ||
| 100 | 1 | |a Zarogoulidis, Paul |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems |
| 264 | 1 | |c 2013 | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Abstract Background Several aerosol production systems have been used for aerosol insulin production. However; since the first studies several new models of jet-nebulizers and ultrasound nebulizers have been introduced in the market. | ||
| 650 | 7 | |a Jet-nebulizers |2 Elsevier | |
| 650 | 7 | |a Aerosol insulin |2 Elsevier | |
| 650 | 7 | |a Ultrasound |2 Elsevier | |
| 700 | 1 | |a Petridis, Dimitris |4 oth | |
| 700 | 1 | |a Ritzoulis, Christos |4 oth | |
| 700 | 1 | |a Li, Qiang |4 oth | |
| 700 | 1 | |a Huang, Haidong |4 oth | |
| 700 | 1 | |a Ning, Yunye |4 oth | |
| 700 | 1 | |a Darwiche, Kaid |4 oth | |
| 700 | 1 | |a Freitag, Lutz |4 oth | |
| 700 | 1 | |a Zarogoulidis, Konstantinos |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Nigolian, H. ELSEVIER |t Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |d 2022 |g New York, NY [u.a.] |w (DE-627)ELV008932840 |
| 773 | 1 | 8 | |g volume:458 |g year:2013 |g number:1 |g day:15 |g month:12 |g pages:39-47 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijpharm.2013.10.019 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.61 |j Innere Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 458 |j 2013 |e 1 |b 15 |c 1215 |h 39-47 |g 9 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
p z pz |
|---|---|
| matchkey_str |
zarogoulidispaulpetridisdimitrisritzouli:2013----:uteeprmnainfnaelnuataiaduuiwtt |
| hierarchy_sort_str |
2013 |
| bklnumber |
44.61 |
| publishDate |
2013 |
| allfields |
10.1016/j.ijpharm.2013.10.019 doi GBVA2013012000020.pica (DE-627)ELV021961824 (ELSEVIER)S0378-5173(13)00905-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Zarogoulidis, Paul verfasserin aut Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems 2013 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Background Several aerosol production systems have been used for aerosol insulin production. However; since the first studies several new models of jet-nebulizers and ultrasound nebulizers have been introduced in the market. Jet-nebulizers Elsevier Aerosol insulin Elsevier Ultrasound Elsevier Petridis, Dimitris oth Ritzoulis, Christos oth Li, Qiang oth Huang, Haidong oth Ning, Yunye oth Darwiche, Kaid oth Freitag, Lutz oth Zarogoulidis, Konstantinos oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:458 year:2013 number:1 day:15 month:12 pages:39-47 extent:9 https://doi.org/10.1016/j.ijpharm.2013.10.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 458 2013 1 15 1215 39-47 9 045F 610 |
| spelling |
10.1016/j.ijpharm.2013.10.019 doi GBVA2013012000020.pica (DE-627)ELV021961824 (ELSEVIER)S0378-5173(13)00905-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Zarogoulidis, Paul verfasserin aut Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems 2013 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Background Several aerosol production systems have been used for aerosol insulin production. However; since the first studies several new models of jet-nebulizers and ultrasound nebulizers have been introduced in the market. Jet-nebulizers Elsevier Aerosol insulin Elsevier Ultrasound Elsevier Petridis, Dimitris oth Ritzoulis, Christos oth Li, Qiang oth Huang, Haidong oth Ning, Yunye oth Darwiche, Kaid oth Freitag, Lutz oth Zarogoulidis, Konstantinos oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:458 year:2013 number:1 day:15 month:12 pages:39-47 extent:9 https://doi.org/10.1016/j.ijpharm.2013.10.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 458 2013 1 15 1215 39-47 9 045F 610 |
| allfields_unstemmed |
10.1016/j.ijpharm.2013.10.019 doi GBVA2013012000020.pica (DE-627)ELV021961824 (ELSEVIER)S0378-5173(13)00905-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Zarogoulidis, Paul verfasserin aut Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems 2013 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Background Several aerosol production systems have been used for aerosol insulin production. However; since the first studies several new models of jet-nebulizers and ultrasound nebulizers have been introduced in the market. Jet-nebulizers Elsevier Aerosol insulin Elsevier Ultrasound Elsevier Petridis, Dimitris oth Ritzoulis, Christos oth Li, Qiang oth Huang, Haidong oth Ning, Yunye oth Darwiche, Kaid oth Freitag, Lutz oth Zarogoulidis, Konstantinos oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:458 year:2013 number:1 day:15 month:12 pages:39-47 extent:9 https://doi.org/10.1016/j.ijpharm.2013.10.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 458 2013 1 15 1215 39-47 9 045F 610 |
| allfieldsGer |
10.1016/j.ijpharm.2013.10.019 doi GBVA2013012000020.pica (DE-627)ELV021961824 (ELSEVIER)S0378-5173(13)00905-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Zarogoulidis, Paul verfasserin aut Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems 2013 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Background Several aerosol production systems have been used for aerosol insulin production. However; since the first studies several new models of jet-nebulizers and ultrasound nebulizers have been introduced in the market. Jet-nebulizers Elsevier Aerosol insulin Elsevier Ultrasound Elsevier Petridis, Dimitris oth Ritzoulis, Christos oth Li, Qiang oth Huang, Haidong oth Ning, Yunye oth Darwiche, Kaid oth Freitag, Lutz oth Zarogoulidis, Konstantinos oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:458 year:2013 number:1 day:15 month:12 pages:39-47 extent:9 https://doi.org/10.1016/j.ijpharm.2013.10.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 458 2013 1 15 1215 39-47 9 045F 610 |
| allfieldsSound |
10.1016/j.ijpharm.2013.10.019 doi GBVA2013012000020.pica (DE-627)ELV021961824 (ELSEVIER)S0378-5173(13)00905-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Zarogoulidis, Paul verfasserin aut Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems 2013 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Background Several aerosol production systems have been used for aerosol insulin production. However; since the first studies several new models of jet-nebulizers and ultrasound nebulizers have been introduced in the market. Jet-nebulizers Elsevier Aerosol insulin Elsevier Ultrasound Elsevier Petridis, Dimitris oth Ritzoulis, Christos oth Li, Qiang oth Huang, Haidong oth Ning, Yunye oth Darwiche, Kaid oth Freitag, Lutz oth Zarogoulidis, Konstantinos oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:458 year:2013 number:1 day:15 month:12 pages:39-47 extent:9 https://doi.org/10.1016/j.ijpharm.2013.10.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 458 2013 1 15 1215 39-47 9 045F 610 |
| language |
English |
| source |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:458 year:2013 number:1 day:15 month:12 pages:39-47 extent:9 |
| sourceStr |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:458 year:2013 number:1 day:15 month:12 pages:39-47 extent:9 |
| format_phy_str_mv |
Article |
| bklname |
Innere Medizin |
| institution |
findex.gbv.de |
| topic_facet |
Jet-nebulizers Aerosol insulin Ultrasound |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| authorswithroles_txt_mv |
Zarogoulidis, Paul @@aut@@ Petridis, Dimitris @@oth@@ Ritzoulis, Christos @@oth@@ Li, Qiang @@oth@@ Huang, Haidong @@oth@@ Ning, Yunye @@oth@@ Darwiche, Kaid @@oth@@ Freitag, Lutz @@oth@@ Zarogoulidis, Konstantinos @@oth@@ |
| publishDateDaySort_date |
2013-01-15T00:00:00Z |
| hierarchy_top_id |
ELV008932840 |
| dewey-sort |
3610 |
| id |
ELV021961824 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV021961824</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623162637.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2013.10.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013012000020.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV021961824</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(13)00905-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zarogoulidis, Paul</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Background Several aerosol production systems have been used for aerosol insulin production. However; since the first studies several new models of jet-nebulizers and ultrasound nebulizers have been introduced in the market.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Jet-nebulizers</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Aerosol insulin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ultrasound</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petridis, Dimitris</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ritzoulis, Christos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Qiang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huang, Haidong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ning, Yunye</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Darwiche, Kaid</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Freitag, Lutz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zarogoulidis, Konstantinos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:458</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:15</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:39-47</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2013.10.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">458</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">15</subfield><subfield code="c">1215</subfield><subfield code="h">39-47</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Zarogoulidis, Paul |
| spellingShingle |
Zarogoulidis, Paul ddc 610 bkl 44.61 Elsevier Jet-nebulizers Elsevier Aerosol insulin Elsevier Ultrasound Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems |
| authorStr |
Zarogoulidis, Paul |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008932840 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.61 bkl Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems Jet-nebulizers Elsevier Aerosol insulin Elsevier Ultrasound Elsevier |
| topic |
ddc 610 bkl 44.61 Elsevier Jet-nebulizers Elsevier Aerosol insulin Elsevier Ultrasound |
| topic_unstemmed |
ddc 610 bkl 44.61 Elsevier Jet-nebulizers Elsevier Aerosol insulin Elsevier Ultrasound |
| topic_browse |
ddc 610 bkl 44.61 Elsevier Jet-nebulizers Elsevier Aerosol insulin Elsevier Ultrasound |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
d p dp c r cr q l ql h h hh y n yn k d kd l f lf k z kz |
| hierarchy_parent_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| hierarchy_parent_id |
ELV008932840 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008932840 |
| title |
Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems |
| ctrlnum |
(DE-627)ELV021961824 (ELSEVIER)S0378-5173(13)00905-8 |
| title_full |
Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems |
| author_sort |
Zarogoulidis, Paul |
| journal |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| journalStr |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
zzz |
| container_start_page |
39 |
| author_browse |
Zarogoulidis, Paul |
| container_volume |
458 |
| physical |
9 |
| class |
610 610 DE-600 610 VZ 44.61 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Zarogoulidis, Paul |
| doi_str_mv |
10.1016/j.ijpharm.2013.10.019 |
| dewey-full |
610 |
| title_sort |
further experimentation of inhaled; lantus, actrapid and humulin with todays’ production systems |
| title_auth |
Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems |
| abstract |
Abstract Background Several aerosol production systems have been used for aerosol insulin production. However; since the first studies several new models of jet-nebulizers and ultrasound nebulizers have been introduced in the market. |
| abstractGer |
Abstract Background Several aerosol production systems have been used for aerosol insulin production. However; since the first studies several new models of jet-nebulizers and ultrasound nebulizers have been introduced in the market. |
| abstract_unstemmed |
Abstract Background Several aerosol production systems have been used for aerosol insulin production. However; since the first studies several new models of jet-nebulizers and ultrasound nebulizers have been introduced in the market. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
1 |
| title_short |
Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems |
| url |
https://doi.org/10.1016/j.ijpharm.2013.10.019 |
| remote_bool |
true |
| author2 |
Petridis, Dimitris Ritzoulis, Christos Li, Qiang Huang, Haidong Ning, Yunye Darwiche, Kaid Freitag, Lutz Zarogoulidis, Konstantinos |
| author2Str |
Petridis, Dimitris Ritzoulis, Christos Li, Qiang Huang, Haidong Ning, Yunye Darwiche, Kaid Freitag, Lutz Zarogoulidis, Konstantinos |
| ppnlink |
ELV008932840 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ijpharm.2013.10.019 |
| up_date |
2024-07-06T20:51:40.532Z |
| _version_ |
1803864349639442432 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV021961824</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623162637.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2013.10.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013012000020.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV021961824</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(13)00905-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zarogoulidis, Paul</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Background Several aerosol production systems have been used for aerosol insulin production. However; since the first studies several new models of jet-nebulizers and ultrasound nebulizers have been introduced in the market.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Jet-nebulizers</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Aerosol insulin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ultrasound</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petridis, Dimitris</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ritzoulis, Christos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Qiang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huang, Haidong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ning, Yunye</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Darwiche, Kaid</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Freitag, Lutz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zarogoulidis, Konstantinos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:458</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:15</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:39-47</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2013.10.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">458</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">15</subfield><subfield code="c">1215</subfield><subfield code="h">39-47</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.400485 |